Contineum Therapeutics
$17.12
1
-$0.45-2.56% 16:26 Today
Statistics
Day High
17.71
Day Low
16.99
52W High
17.79
52W Low
8.6
Volume
120,742
Avg. Volume
432,798
Mkt Cap
644.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.62
-0.54
-0.47
-0.39
Expected EPS
-0.4539
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-59.98MNet Income
Analyst Ratings
19.50Average Price Target
The highest estimate is 23.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CTNM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
Show more...
CEO
Carmine N. Stengone
Employees
51
Country
United States
ISIN
US21217B1008
Listings
0 Comments
Share your thoughts
FAQ
What is Contineum Therapeutics stock price today?▼
The current price of CTNM is $17.12 USD — it has decreased by -2.56% in the past 24 hours. Watch Contineum Therapeutics stock price performance more closely on the chart.
What is Contineum Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Contineum Therapeutics stocks are traded under the ticker CTNM.
Is Contineum Therapeutics stock price growing?▼
CTNM stock has risen by +0.15% compared to the previous week, the month change is a +7.39% rise, over the last year Contineum Therapeutics has showed a +55.37% increase.
What is Contineum Therapeutics market cap?▼
Today Contineum Therapeutics has the market capitalization of 644.07M
When is the next Contineum Therapeutics earnings date?▼
Contineum Therapeutics is going to release the next earnings report on November 11, 2026.
What were Contineum Therapeutics earnings last quarter?▼
CTNM earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.45 USD resulting in a +10.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Contineum Therapeutics revenue for the last year?▼
Contineum Therapeutics revenue for the last year amounts to 0 USD.
What is Contineum Therapeutics net income for the last year?▼
CTNM net income for the last year is -59.98M USD.
How many employees does Contineum Therapeutics have?▼
As of September 04, 2026, the company has 51 employees.
In which sector is Contineum Therapeutics located?▼
Contineum Therapeutics operates in the Health & Wellness sector.
When did Contineum Therapeutics complete a stock split?▼
Contineum Therapeutics has not had any recent stock splits.
Where is Contineum Therapeutics headquartered?▼
Contineum Therapeutics is headquartered in SAN DIEGO, United States.